ID   CHLA-123
AC   CVCL_A060
DR   Cosmic; 930050
DR   Cosmic; 1019952
DR   Cosmic; 1109361
DR   Wikidata; Q54812156
RX   PubMed=11212268;
RX   PubMed=16822308;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 12,19
ST   D19S433: 13,15
ST   D21S11: 32.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 9
//
RX   PubMed=16822308; DOI=10.1186/1471-2407-6-177; PMCID=PMC1533846;
RA   Dam, Vincent
RA   Morgan, Brian T.
RA   Mazanek, Pavel
RA   Hogarty, Michael D.
RT   "Mutations in PIK3CA are infrequent in neuroblastoma.";
RL   BMC Cancer 6:177.1-177.10(2006).
//
RX   PubMed=11212268;
RA   Thompson, Patricia M.
RA   Maris, John Matthew
RA   Hogarty, Michael D.
RA   Seeger, Robert C.
RA   Reynolds, Charles Patrick
RA   Brodeur, Garrett M.
RA   White, Peter S.
RT   "Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36
RT   or at other tumor suppressor loci in neuroblastoma.";
RL   Cancer Res. 61:679-686(2001).
//